Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Cash from Investing Activities (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Cash from Investing Activities for 16 consecutive years, with -$10.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 857.8% year-over-year to -$10.9 million, compared with a TTM value of -$34.6 million through Dec 2025, down 25.45%, and an annual FY2025 reading of -$34.6 million, down 25.45% over the prior year.
  • Cash from Investing Activities was -$10.9 million for Q4 2025 at Orthofix Medical, down from -$9.9 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $17.1 million in Q1 2023 and bottomed at -$22.3 million in Q3 2023.
  • Average Cash from Investing Activities over 5 years is -$7.1 million, with a median of -$6.9 million recorded in 2025.
  • The sharpest move saw Cash from Investing Activities skyrocketed 401.46% in 2023, then tumbled 857.8% in 2025.
  • Year by year, Cash from Investing Activities stood at -$9.0 million in 2021, then surged by 34.31% to -$5.9 million in 2022, then tumbled by 155.14% to -$15.1 million in 2023, then soared by 92.46% to -$1.1 million in 2024, then crashed by 857.8% to -$10.9 million in 2025.
  • Business Quant data shows Cash from Investing Activities for OFIX at -$10.9 million in Q4 2025, -$9.9 million in Q3 2025, and -$7.1 million in Q2 2025.